IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aihc Capital Management Ltd

Q4 2025 Holdings

Filed 2026-02-05 | 6 holdings | $106.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revolution Medicines Inc(RVMD)COM76155X100$71.7M900,39267.2%
Protagonist Therapeutics Inc(PTGX)COM74366E102$16.6M189,82315.5%
Arrivent Biopharma Inc(AVBP)COM04272N102$13.0M644,78812.2%
Cogent Biosciences Inc(COGT)COM19240Q201$3.6M100,0003.3%
Novabridge Biosciences(NBP)SPONSORED ADS44975P103$1.6M413,9791.5%
Korro BIO Inc(KRRO)COM500946108$242.4K30,2650.2%